Jaguar动物健康 JAGX 深 沪
已收盘 07-24 16:00:00 美东时间
0.9633
-0.067
-6.48%
华盛通- 最 高1.08
- 今 开1.04
- 成交量 19.35万股
- 最 低 0.95
- 昨 收 1.03
- 总市值 473.02万
- 52周最高 92.75
- 市盈率 静 --
- 换手率 3.94%
- 52周最低 0.95
- 委 比 -87.34%
- 总股本 491.04万
- 历史最高 87566062500.00
- 量 比 1.35
- 振 幅 12.62%
- 历史最低 0.95
- 每 手 1
- 风险率 27.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jaguar Health Completes Conversion of Series O Preferred
Jaguar Animal Health ( ($JAGX) ) has issued an announcement. On March 4, 2026, ...
07-02 05:01
Jaguar Health Board Initiates Review Of Strategic Alternatives To Maximize Shareholder Value, Aligned With Anticipated NDA Filing For Crofelemer Candidate In Rare Intestinal Failure Diseases
Reminder: Lisa Conte, Jaguar's founder & CEO, to present on June 24, 2026 at the Life Sciences Virtual Investor Forum to provide updates on company's crofelemer development program for rare intestinal failure diseases; click here to register SAN FRANCISCO, CA / ACCESS Newswire / June 22, 2026 / Jagu...
06-22 21:05
Jaguar Health CEO To Present At Life Sciences Virtual Investor Forum
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Wednesday, June 24, 2026 at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com.
06-12 21:03
Jaguar Health Shareholders Approve Financing and Governance Proposals
An announcement from Jaguar Animal Health ( ($JAGX) ) is now available. On June...
06-09 05:56
Jaguar Animal Health Postpones 2026 Stockholder Meeting Again
Jaguar Animal Health ( ($JAGX) ) has issued an announcement. On May 19, 2026, J...
06-03 05:28
电话会总结 ｜ Jaguar Health(JAGX)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Jaguar Health业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2025财年第三季度合并净营收约310万美元，环比增长约4%（较2025财年第二季度的300万美元），同比持平（与2024财年第三季度的310万美元相等）。 **亏损情况：** - 归属于普通股股东的净亏损为950万美元，较2024财年第三季度的990万美元减少35.2万美元 - 运营亏损为730万美元，较2024财年第三季度的720万美元增加2.4万美元 - 非GAAP经常性EBITDA净亏损为890万美元，较2024财年第三季度的920
05-22 12:20
Jaguar Health Q1 EPS $(13.60) Misses $(4.26) Estimate, Sales $20.272M Beat $4.211M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(13.60) per share which missed the analyst consensus estimate of $(4.26) by 219.25 percent. This is a 97.67 percent increase over losses of $(584.45) per share
05-21 05:02
Jaguar Health's Napo Pharmaceuticals Announces That First Patient From Cohort Of Pediatric MVID Patients Has Entered The Active Treatment Only Single-Blind Extension To Study Safety And Efficacy
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) announced that the first patient from the cohort of pediatric MVID patients in the pivotal MVID randomized double-blind
05-19 21:11
Jaguar Health Stock Surges On FDA Breakthrough Discussions For Rare Disease Therapy
Jaguar Health Inc. shares are climbing Wednesday after preliminary FDA talks on Breakthrough Therapy Designation for oral liquid crofelemer.
05-06 21:26
